×
About 2,985 results

ALLMedicine™ Intrauterine Device Center

Research & Reviews  977 results

Endometrial Cancer Treatment Protocols
https://emedicine.medscape.com/article/2001830-overview

May 18th, 2022 - Treatment Protocols Treatment protocols for endometrial cancer are provided below, including the following: General treatment recommendations Recommendations for limited, metastatic, recurrent, and high-risk disease Risk classifications General tr...

Method of Hormonal Contraception and Protective Effects Against Ectopic Pregnancy.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015020
Obstetrics and Gynecology; Kopp-Kallner H, Linder M et. al.

May 17th, 2022 - To estimate the incidence rates for ectopic pregnancy by contraceptive method in a cohort of women using hormonal contraception in Sweden between 2005 and 2016. Women aged 15-49 years with a filled prescription for a hormonal contraceptive in the ...

Update on Incidence of Inpatient Tubal Ligation and Long-acting Reversible Contraceptio...
https://doi.org/10.1016/j.ajog.2022.05.021
American Journal of Obstetrics and Gynecology; Fang NZ, Westhoff CL

May 16th, 2022 - Inpatient insertion of long-acting reversible contraception (LARC) and immediate postpartum tubal ligation allow women to initiate highly effective contraception prior to hospital discharge. We measured rates of intrauterine device (IUD) and contr...

What are the prospects for the hormonal IUD in the public sector? A mixed-method study ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107745
BMC Women's Health; Brunie A, Lydon M et. al.

May 16th, 2022 - The levonorgestrel-releasing intrauterine device (IUD)-also known as the hormonal IUD-is a highly effective contraceptive method that has not been widely available in the public sector in Zambia. Early introduction efforts can provide critical ins...

Early Versus Late Interval Postpartum Copper Intrauterine Device Insertion
https://clinicaltrials.gov/ct2/show/NCT03106805

May 11th, 2022 - The optimal interval between pregnancies is debated, but a duration greater than 11-18 months has been suggested as reducing complications in the subsequent pregnancy. Improved birth spacing can be a key benefit use of long-acting reversible contr...

see more →

Guidelines  1 results

Canadian Contraception Consensus (Part 2 of 4).
https://www.ncbi.nlm.nih.gov/pubmed/26629725
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Black A, Guilbert E et. al.

Dec 3rd, 2015 - To provide guidelines for health care providers on the use of contraceptive methods to prevent pregnancy and on the promotion of healthy sexuality. Guidance for Canadian practitioners on overall effectiveness, mechanism of action, indications, con...

see more →

Drugs  11 results see all →

Clinicaltrials.gov  67 results

Early Versus Late Interval Postpartum Copper Intrauterine Device Insertion
https://clinicaltrials.gov/ct2/show/NCT03106805

May 11th, 2022 - The optimal interval between pregnancies is debated, but a duration greater than 11-18 months has been suggested as reducing complications in the subsequent pregnancy. Improved birth spacing can be a key benefit use of long-acting reversible contr...

Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer
https://clinicaltrials.gov/ct2/show/NCT00788671

Apr 28th, 2022 - PRIMARY OBJECTIVES: I. To determine the efficacy of the levonorgestrel intrauterine device (IUD) (levonorgestrel-releasing intrauterine system) to treat complex atypical hyperplasia (CAH) and grade 1 endometrioid endometrial carcinoma (G1 EEC). II...

Insertion of Copper T380 Versus Multiload IUD Post Partum
https://clinicaltrials.gov/ct2/show/NCT05283798

Mar 17th, 2022 - Insertion of an intrauterine device (IUD) immediately after delivery is appealing for several reasons. The woman is known not to be pregnant, her motivation for contraception may be high, and the setting may be convenient for both the woman and he...

Uterine Anatomical Flexion Degree ( Uterocervical Angle) and Intrauterine Device (IUD) Dislocation
https://clinicaltrials.gov/ct2/show/NCT05263544

Mar 2nd, 2022 - IUD (intrauterine device) is one of the most preferred birth control methods in our country and in the world, and this usage rate is approximately 23% in the world. In our country, this rate is around 17%. The high chance of success, ease of use a...

Lidocaine Spray 10% Versus Oral Ibuprofen Tablets in Pain Control During Copper Intrauterine Device Insertion
https://clinicaltrials.gov/ct2/show/NCT05241496

Mar 2nd, 2022 - The aim of this study is to This study is designed to compare between lidocaine spray 10% and oral ibuprofen as an adequate method for decreasing pain during copper intrauterine contraceptive device insertion . Research question: Which of both dru...

see more →

News  135 results

IUD Cuts Heavy Menses in Nulliparous Patients With Obesity
https://www.medscape.com/viewarticle/973464

May 5th, 2022 - New phase 3 data support the use of the levonorgestrel 52 mg intrauterine device (IUD) in nulliparous women with obesity and heavy menstrual bleeding. The findings, presented at the 2022 annual meeting of the American College of Obstetricians and ...

When and When Not to Prescribe Contraception Remotely Under the Spotlight
https://www.medscape.com/viewarticle/961140

Oct 19th, 2021 - The progesterone only pill is generally safe to be prescribed remotely, because recent blood pressure and weight are not required according to a session on remote prescribing in women’s health at the Royal College of General Practitioners (RCGP) a...

Uterine perforation rates remain low after intrauterine device insertion
https://www.mdedge.com/obgyn/article/246273/contraception/uterine-perforation-rates-remain-low-after-intrauterine-device

Sep 18th, 2021 - Key clinical point: The overall rate of uterine perforation after intrauterine device (IUD) insertion was less than 1%, but higher with placement at 4-8 weeks postpartum compared to 9-36 weeks postpartum. Major finding: After adjusting for multipl.

Contraceptive use lowers levels of anti-Müllerian hormone compared with non-use
https://www.mdedge.com/obgyn/article/243469/contraception/contraceptive-use-lowers-levels-anti-mullerian-hormone-compared

Jul 27th, 2021 - Key clinical point: Current use of hormonal contraceptives was associated with lower mean levels of anti-Müllerian hormone compared to levels in women not on contraceptives; the data may guide clinicians in counseling women to continue their contr.

Contraceptive Counseling for Transmasculine Patients
https://www.medscape.com/viewarticle/954773

Jul 14th, 2021 - One of the most common reasons patients seek care from an ob.gyn. is for contraceptive counseling and family planning. While prescribing contraceptives for cisgender patients is often part of the daily routine for ob.gyns., many are unfamiliar wit...

see more →

Patient Education  3 results see all →